SPAPB2B4.07 Antibody

What is SPAPB2B4.07 and why is it studied in yeast models?

SPAPB2B4.07 is a specific gene locus in Schizosaccharomyces pombe (fission yeast) that encodes a protein with UniProt accession number Q9HDW4. Fission yeast serves as an exceptional model organism for fundamental cellular processes due to its relatively simple genome while maintaining many features relevant to higher eukaryotes. SPAPB2B4.07 is studied in yeast models to understand conserved cellular mechanisms with potential implications across evolutionary boundaries. Antibodies targeting this protein enable researchers to investigate its expression, localization, interactions, and functional roles within cellular pathways. S. pombe provides a controlled environment for studying fundamental processes without the complexity of mammalian systems while still offering insights translatable to more complex organisms .

What are the optimal storage conditions for SPAPB2B4.07 antibody to maintain its efficacy?

The optimal storage conditions for SPAPB2B4.07 antibody involve maintaining it at either -20°C or -80°C in its storage buffer, which consists of 50% glycerol, 0.01M PBS at pH 7.4, and 0.03% Proclin 300 as a preservative. It's crucial to avoid repeated freeze-thaw cycles, as these can lead to protein denaturation and subsequent loss of antibody activity. For working solutions, short-term storage at 4°C (up to one week) is generally acceptable. When handling the antibody, researchers should always wear gloves to prevent contamination and avoid unnecessary exposure to room temperature. Aliquoting the antibody upon first thaw into single-use volumes significantly extends shelf life by eliminating the need for multiple freeze-thaw cycles .

What applications is SPAPB2B4.07 antibody validated for in research settings?

SPAPB2B4.07 antibody has been validated for multiple research applications, with ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) being the primary confirmed techniques. In ELISA applications, the antibody can detect native or recombinant SPAPB2B4.07 protein with high sensitivity, allowing for quantitative analysis of protein expression levels. For Western Blot applications, the antibody successfully recognizes denatured SPAPB2B4.07 protein, enabling researchers to determine molecular weight, expression levels, and potential post-translational modifications. The antibody has undergone affinity purification to ensure identification of its target antigen . While not explicitly validated, polyclonal antibodies like this are often suitable for additional applications such as immunoprecipitation (IP) and immunofluorescence (IF), though these would require validation by individual researchers for their specific experimental conditions.

What is the specificity of the SPAPB2B4.07 antibody for S. pombe proteins?

The SPAPB2B4.07 antibody demonstrates high specificity for its target protein in Schizosaccharomyces pombe (strain 972 / ATCC 24843). This specificity derives from its development process, where recombinant SPAPB2B4.07 protein served as the immunogen for antibody production in rabbits. The antibody underwent antigen affinity purification, which enhances its specificity by selecting only those antibody molecules with high binding affinity for the target . When assessing cross-reactivity, researchers should note that this antibody was specifically developed for S. pombe applications, and its reactivity with homologous proteins from other species requires experimental validation. The polyclonal nature means it recognizes multiple epitopes on the SPAPB2B4.07 protein, which provides robust detection but may also increase the potential for cross-reactivity with structurally similar proteins.

How does the polyclonal nature of SPAPB2B4.07 antibody affect its research applications?

The polyclonal nature of SPAPB2B4.07 antibody significantly influences its research applications, offering both advantages and considerations. Polyclonal antibodies contain a heterogeneous mixture of immunoglobulins that recognize multiple epitopes on the target protein, in contrast to monoclonal antibodies that bind to a single epitope . This multi-epitope recognition provides enhanced sensitivity, as the collective binding of multiple antibodies to different regions of the target protein amplifies signal detection. This feature makes the SPAPB2B4.07 polyclonal antibody particularly valuable for applications where target protein concentration may be low, or when detecting proteins in native conformation where some epitopes might be inaccessible. Additionally, polyclonal antibodies typically show greater tolerance to minor changes in protein structure or sample preparation conditions, providing more robust detection across varied experimental protocols.

What are the optimal conditions for using SPAPB2B4.07 antibody in chromatin immunoprecipitation experiments?

Chromatin immunoprecipitation (ChIP) using SPAPB2B4.07 antibody requires optimization of several key parameters to ensure successful protein-DNA interaction analysis. Researchers should begin with chromatin crosslinking using 1% formaldehyde for 10-15 minutes at room temperature, followed by quenching with 125 mM glycine. Cell lysis should be performed using mechanical disruption methods effective for yeast cell walls, such as glass bead beating in lysis buffer containing protease inhibitors. Chromatin should be sheared to fragments of 200-500 bp using sonication, with optimization of sonication cycles specific to S. pombe cells. For immunoprecipitation, a typical starting concentration is 2-5 μg of SPAPB2B4.07 antibody per ChIP reaction, though titration experiments are recommended to determine optimal antibody concentration. Critical controls should include a non-specific IgG control and input chromatin samples. The antibody's polyclonal nature may provide advantages in ChIP by recognizing multiple epitopes, potentially increasing the likelihood of binding accessible regions even after crosslinking .

How can SPAPB2B4.07 antibody be used to investigate protein-protein interactions in S. pombe?

SPAPB2B4.07 antibody serves as a valuable tool for investigating protein-protein interactions through several complementary approaches. Co-immunoprecipitation (Co-IP) represents the most direct method, wherein the antibody captures the SPAPB2B4.07 protein along with its interacting partners from cell lysates under native conditions. For Co-IP, researchers should prepare S. pombe lysates using gentle lysis buffers (typically containing 150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1% NP-40 or 0.5% Triton X-100, and protease inhibitors) that preserve protein-protein interactions. The SPAPB2B4.07 antibody (2-5 μg) can be incubated with the lysate overnight at 4°C, followed by capture using Protein A/G beads . After washing to remove non-specific interactions, eluted proteins can be analyzed by mass spectrometry or Western blotting to identify interacting partners. For validation of specific interactions, reciprocal Co-IPs should be performed, and the specificity of interactions can be further confirmed through complementary techniques such as yeast two-hybrid assays.

What are the challenges in validating cross-reactivity of SPAPB2B4.07 antibody with homologous proteins in other yeast species?

Validating cross-reactivity of SPAPB2B4.07 antibody with homologous proteins in other yeast species presents several significant challenges. First, evolutionary divergence between yeast species leads to amino acid sequence variations in homologous proteins, potentially affecting epitope conservation and antibody recognition. Even closely related species may display critical differences in the epitopes recognized by the SPAPB2B4.07 antibody. Second, differences in protein expression levels across yeast species complicate direct comparisons, as lower abundance homologs may yield false negative results despite antibody cross-reactivity. Third, post-translational modifications, which often differ between species, can mask epitopes or create new ones, affecting antibody binding. Fourth, the polyclonal nature of the SPAPB2B4.07 antibody means it recognizes multiple epitopes, some of which may be conserved across species while others are not . To address these challenges, researchers should perform sequential validation steps including in silico sequence analysis, Western blots with positive controls from S. pombe alongside samples from target species, and validation using complementary methods such as mass spectrometry.

How can epitope mapping be performed to characterize the binding sites of SPAPB2B4.07 antibody?

Epitope mapping for SPAPB2B4.07 antibody can be performed through several complementary approaches to identify the specific protein regions recognized by this polyclonal antibody. Peptide array analysis represents a high-resolution method wherein overlapping synthetic peptides (typically 15-20 amino acids with 5-10 amino acid overlap) spanning the entire SPAPB2B4.07 protein sequence are immobilized on a membrane or microarray. The antibody is then incubated with this array, and binding is detected through secondary antibody-conjugated reporters, revealing which peptide fragments contain epitopes. For higher resolution, alanine scanning mutagenesis can be employed, where individual amino acids within identified epitope regions are systematically substituted with alanine to determine critical residues for antibody binding. Alternatively, recombinant protein fragments or deletion mutants of SPAPB2B4.07 can be generated and tested by Western blot to map binding regions . For this polyclonal antibody, researchers should anticipate identifying multiple epitopes rather than a single binding site, necessitating comprehensive analysis to characterize the full range of recognition sites.

What strategies can overcome inconsistent results when using SPAPB2B4.07 antibody in different experimental conditions?

Inconsistent results with SPAPB2B4.07 antibody across different experimental conditions can be addressed through several systematic strategies. First, standardize antibody handling and storage protocols by creating single-use aliquots stored at -80°C to prevent freeze-thaw degradation and maintain consistent antibody concentration across experiments . Second, implement thorough optimization for each specific application by conducting antibody titration experiments to determine the optimal concentration for each technique (Western blot, ELISA, etc.), and systematically varying key parameters such as incubation time, temperature, and buffer composition. Third, standardize sample preparation methods across experiments, paying particular attention to lysis buffer composition, protease inhibitors, and extraction conditions that may affect epitope accessibility. Fourth, implement robust positive and negative controls in each experiment, including S. pombe wild-type samples (positive control) and samples from deletion strains lacking the SPAPB2B4.07 gene (negative control). Fifth, validate results using complementary approaches, such as confirming Western blot findings with ELISA or mass spectrometry.

What is the recommended protocol for optimizing SPAPB2B4.07 antibody concentration in Western blot applications?

Optimizing SPAPB2B4.07 antibody concentration for Western blot applications requires a systematic titration approach to balance specific signal detection with minimal background. Begin by preparing a dilution series of the antibody, typically ranging from 1:500 to 1:5,000 in primary antibody dilution buffer (typically PBS or TBS with 0.05-0.1% Tween-20 and 1-5% blocking agent such as non-fat dry milk or BSA). Prepare identical Western blot membranes with both positive control samples (S. pombe lysates expressing SPAPB2B4.07) and negative control samples (ideally from SPAPB2B4.07 knockout strains, or alternatively, lysates from distant species). Incubate each membrane with a different antibody dilution, keeping all other conditions constant . After washing, proceed with appropriate secondary antibody incubation (typically anti-rabbit IgG-HRP at 1:5,000 to 1:10,000) and development using chemiluminescence or other detection methods.

How can researchers validate the specificity of SPAPB2B4.07 antibody in their experimental systems?

Validating the specificity of SPAPB2B4.07 antibody requires a multi-faceted approach to ensure reliable experimental outcomes. The gold standard for specificity validation involves comparing signal detection between wild-type samples and those from genetic knockouts or knockdowns of the SPAPB2B4.07 gene. In this approach, a specific antibody should show clear signal in wild-type S. pombe samples and absence of signal in knockout samples. If genetic manipulation is not feasible, competitive blocking experiments provide an alternative validation method. Here, the antibody is pre-incubated with excess purified recombinant SPAPB2B4.07 protein before application to samples; specific binding will be blocked, resulting in signal reduction or elimination . Another approach involves immunodepletion, where the antibody is used to sequentially immunoprecipitate SPAPB2B4.07 from a sample until it is depleted, with Western blot analysis confirming complete removal of the target protein. Molecular weight verification is essential, as the detected protein should migrate at the expected molecular weight for SPAPB2B4.07 (researchers should consult UniProt entry Q9HDW4 for predicted molecular weight, accounting for potential post-translational modifications).

What controls should be included when using SPAPB2B4.07 antibody in immunofluorescence studies?

Immunofluorescence studies using SPAPB2B4.07 antibody require rigorous controls to ensure reliable and interpretable results. Primary controls should include: (1) Positive Control: Wild-type S. pombe cells known to express SPAPB2B4.07 protein, processed identically to experimental samples; (2) Negative Control - Genetic: Ideally, SPAPB2B4.07 knockout or knockdown strains to confirm signal specificity; (3) Primary Antibody Controls: Omission control (samples processed without primary antibody), isotype control (non-specific rabbit IgG at the same concentration), and pre-absorption control (primary antibody pre-incubated with excess recombinant SPAPB2B4.07 protein) . Additional controls should include fixation controls (comparing multiple fixation methods), permeabilization controls (testing different permeabilization conditions), and subcellular marker co-localization (co-staining with established subcellular markers). Signal specificity controls should include concentration gradient testing (multiple primary antibody dilutions) and cross-species controls (testing the antibody on distantly related species). Technical controls should address autofluorescence (samples processed without any antibodies) and bleed-through (single-labeled samples to ensure proper filter separation in multi-color experiments).

What are the recommended approaches for troubleshooting high background when using SPAPB2B4.07 antibody?

Troubleshooting high background when using SPAPB2B4.07 antibody requires a systematic approach addressing multiple potential causes. First, optimize blocking conditions by testing different blocking agents (BSA, non-fat dry milk, normal serum, commercial blocking buffers) at various concentrations (3-5%) and extended blocking times (1-2 hours at room temperature or overnight at 4°C). Second, increase washing stringency by extending wash durations (5-10 minutes per wash), increasing the number of washes (5-6 times), and adding additional detergent to wash buffers (0.1-0.3% Tween-20 or 0.05-0.1% Triton X-100). Third, dilute the primary antibody further, testing a broader range of dilutions to identify the optimal concentration that maintains specific signal while reducing background . Fourth, reduce secondary antibody concentration, typically using 1:10,000 to 1:20,000 dilutions for enzyme-conjugated antibodies. Fifth, pre-absorb the SPAPB2B4.07 antibody with non-specific proteins by incubating it with S. pombe lysate from a SPAPB2B4.07 knockout strain or with commercially available non-specific protein mixtures. For application-specific troubleshooting: in Western blots, fresh transfer buffers and appropriate membrane blocking are critical; in immunofluorescence, autofluorescence can be reduced using quenching agents.

How can SPAPB2B4.07 antibody be conjugated to fluorophores or enzymes for specialized applications?

Conjugation of SPAPB2B4.07 antibody to fluorophores or enzymes enables specialized applications such as direct immunofluorescence, flow cytometry, or enzyme-linked detection without secondary antibodies. The process begins with antibody concentration determination using absorbance at 280 nm (typical IgG extinction coefficient: 1.4 for 1 mg/ml solution). For optimal conjugation, antibody concentration should be adjusted to 1-2 mg/ml in conjugation buffer (typically PBS), and the buffer should be exchanged if the storage buffer contains primary amines (e.g., Tris) or sodium azide that may interfere with conjugation chemistry . For fluorophore conjugation, NHS ester-activated dyes (e.g., Alexa Fluor, Cy dyes, FITC) react with primary amines on antibodies. The recommended dye-to-antibody molar ratio ranges from 4:1 to 10:1 depending on the specific fluorophore, with reaction conditions typically involving 1-2 hour incubation at room temperature (pH 8.0-8.5). For enzyme conjugation (e.g., HRP, alkaline phosphatase), protocols vary based on the chemistry employed. Post-conjugation purification is critical to remove unreacted label, typically achieved through gel filtration or dialysis.